Table 1 Study participant demographics, clinical and biochemical data
From: Transient increase in CSF GAP-43 concentration after ischemic stroke
Controls | Stroke patients | |
|---|---|---|
Demographics | ||
No. | 19 | 28 |
Age | 66 (±7) | 64 (±11) |
Gender (% male) | 47% | 75% |
SSI 0 < 15 < 30 (n) | 23/ 5/ 0 | |
White matter lesion: normal/sporadic/moderate/ pronounced (n) | 9/ 8/ 4/ 3 | |
Atrophy: normal/ general sporadic/general moderate/cortical sporadic (n) | 15/ 1/ 3/ 5 | |
GAP-43 (pg/ml) | 2711 (2021–3602) | |
Day 0–1 (n = 8) | 2008 (1762–2954) | |
Day2–4 (n = 23) | 3311 (2057–5491) | |
Day7–9 (n = 26) | 3819 (2531–7242) | |
3 weeks (n = 22) | 3949 (2668–6606) | |
3–5 months (n = 24) | 2562 (2112–2821) | |